Celgene Corporation’s $5 Billion Bridge Commitment and $1 Billion Revolving Credit Facility
July 29, 2015
Cravath represented JPMorgan Chase Bank, N.A. as arranger of a $5 billion bridge commitment and a $1 billion revolving credit facility to support Celgene Corporation’s acquisition of Receptos, Inc. Celgene Corporation is a global biopharmaceutical company with a primary focus in developing therapies to treat cancer and inflammatory diseases. The transaction closed on July 29, 2015.
The Cravath team included partners James D. Cooper and Stephen L. Burns, senior attorney Patrick J. Moriarty and associates Jacob B. Ornstein and Saarah Woodby on banking and securities matters; and partner David J. Kappos and senior attorney Anthony N. Magistrale on intellectual property matters. Summer associate Stephanie M. Park also worked on banking matters.
Related Practices & Industries
People
- Photo
-
-
J.D., 1990, University of California, Berkeley, School of Law
-
B.S., 1983, University of California, Davissumma cum laude
- New York
- California
- District of Columbia
Education
Admitted In
- Photo
-
-
J.D., 1979, Yale Law School
-
A.B., 1976, University of ChicagoPhi Beta Kappa, summa cum laude
Education
- Photo
-
-
J.D., 1990, The University of Texas School of Lawwith Honors
-
B.B.A., 1987, University of Oklahomawith Distinction
Education
Related News & Insights
Deals & Cases
April 06, 2026
Versigent’s $1.35 Billion Credit Facilities and $1.6 Billion High‑Yield Senior Notes Offering in Connection with Aptiv PLC’s Spin‑Off of Versigent
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $1.35 billion of credit facilities made available to subsidiaries of Versigent Limited, a global leader in the design, development and manufacture of low voltage and high voltage electrical architectures and the holding company for Aptiv PLC’s Electrical Distribution Systems segment, which Aptiv PLC spun off into a separate, independent, publicly traded company. The proceeds were used to partially finance the spin‑off. The credit facilities consisted of a $500 million term loan facility and an $850 million revolving credit facility. The transaction closed on November 26, 2025.
Deals & Cases
February 20, 2026
First Solar’s $1.5 Billion Revolving Credit Facility
Cravath represented First Solar, Inc. in connection with its $1.5 billion revolving credit facility. First Solar is America’s leading photovoltaic solar technology and manufacturing company, and the only US‑headquartered company among the world’s largest solar manufacturers. The transaction closed on February 13, 2026.
Deals & Cases
January 08, 2026
Genmab’s $3.5 Billion of Credit Facilities and Offering of $1.5 Billion Senior Secured Notes and $1 Billion Senior Unsecured Notes in Connection with its Acquisition of Merus
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $3.5 billion of credit facilities made available to Genmab, a leading international biotechnology company, and one of its wholly‑owned subsidiaries, Genmab Finance LLC, as part of the financing transactions undertaken in connection with its acquisition of Merus N.V., a leading oncology company developing innovative antibody therapeutics. The credit facilities consisted of a $2 billion term loan “B” facility, a $1 billion term loan “A” facility and a $500 million revolving credit facility. The transaction closed on December 12, 2025.
Deals & Cases
December 24, 2025
Ameren’s $3.2 Billion of Revolving Credit Facilities
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with $3.2 billion of revolving credit facilities made available to Ameren Corporation and Union Electric Company (the “Missouri Borrowers”) and Ameren Corporation and Ameren Illinois Company (the “Illinois Borrowers”). Ameren Corporation is an American power company that engages in the rate‑regulated electric generation, transmission and distribution activities; and rate‑regulated natural gas distribution and transmission businesses. The facilities consisted of a $1.9 billion revolving credit facility (Missouri Borrowers) and $1.3 billion revolving credit facility (Illinois Borrowers). The transaction closed on December 10, 2025.
